@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CT3B661K-M
  skos:prefLabel "Radiosensibilisants"@fr, "Radiation-Sensitizing Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-JSSRTQMN-X
  skos:altLabel "5-Bromo-2'-désoxyuridine"@fr, "BrdU"@en, "BrdU"@fr, "5-Bromo-2'-deoxyuridine"@en, "G34N38R2N1"@fr, "G34N38R2N1"@en, "Bromodésoxyuridine"@fr, "Uridine, 5-bromo-2'-deoxy-"@fr, "Uridine, 5-bromo-2'-deoxy-"@en, "Bromouracil Deoxyriboside"@en, "59-14-3 (Bromodeoxyuridine)"@fr, "59-14-3 (Bromodeoxyuridine)"@en, "Broxuridine"@en, "BUdR"@en, "5-Bromodeoxyuridine"@en ;
  mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-TJHVZCRZ-0, jvr:-H7K65Q8S-Z, jvr:-Q3979798-W, jvr:-BT300B3G-Q, jvr:-NKM836P1-M, jvr:-W6SQV79N-S, jvr:-T9HQD7ST-J, jvr:-FWD2BGQ0-9, jvr:-R0ZCQ8X6-J, jvr:-D0F21513-5, jvr:-CB30NGKB-3, jvr:-WK5F724J-1, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-M63HSDM7-1, jvr:-R3QWLHRG-V, jvr:-XV06LPML-W, jvr:-S0CS1X5R-5, jvr:-G30ZJ446-J, jvr:-G4R176S9-J, jvr:-THHNVC7V-3, jvr:-NFTHND7Q-8, jvr:-NB0XHT3S-N, jvr:-SBNWSM1T-R ;
  mesh:pharmacologicalAction jvr:-X5PJJJ2Q-P, jvr:-RLGZ62D2-Z, jvr:-WJFDLBW4-7, jvr:-CT3B661K-M ;
  dc:established "1966-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:prefLabel "Bromodeoxyuridine"@en, "Broxuridine"@fr ;
  skos:hiddenLabel "NSC-38297"@fr, "NSC-38297"@en, "NSC38297"@fr ;
  skos:definition "A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors."@en ;
  a skos:Concept, mesh:Descriptor ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D001973> ;
  skos:broader jvr:-Q06327MZ-M ;
  dc:modified "2016-05-27"^^xsd:date ;
  dc:created "1999-01-01"^^xsd:date .

jvr:-RLGZ62D2-Z
  skos:prefLabel "Antimétabolites antinéoplasiques"@fr, "Antimetabolites, Antineoplastic"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-WJFDLBW4-7
  skos:prefLabel "Antimetabolites"@en, "Antimétabolites"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q06327MZ-M
  skos:prefLabel "Désoxyuridine"@fr, "Deoxyuridine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-JSSRTQMN-X .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X5PJJJ2Q-P
  skos:prefLabel "Antiviral Agents"@en, "Antiviraux"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .